Projects per year
Personal profile
Headline
ASSOCIATE PROFESSOR Medicine, Hematology and Medical Oncology
Biography
Fingerprint
Dive into the research topics where Hearn Cho is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 3 Finished
-
Novel therapeutic strategies targeting conformational plasticity of type I MAGE
19/12/14 → 30/11/15
Project: Research
-
-
Type I MAGE mRNA-pulsed dendritic cell vaccines for multiple myeloma
Multiple Myeloma Research Foundation
1/01/06 → 31/12/06
Project: Research
-
Bridging advanced myeloma patients to subsequent treatments and clinical trials with classical chemotherapy and stem cell support
Mouhieddine, T. H., Moshier, E., Thibaud, S., Puliafito, B., Rattu, M., Jakubowski, R., Sanchez, L., Rossi, A., Rodriguez, C., Richard, S., Cho, H. J., Parekh, S., Chari, A., Steinberg, A. & Richter, J., Jan 2023, In: Bone Marrow Transplantation. 58, 1, p. 80-86 7 p.Research output: Contribution to journal › Article › peer-review
-
Cross center single-cell RNA sequencing study of the immune microenvironment in rapid progressing multiple myeloma
Pilcher, W., Thomas, B. E., Bhasin, S. S., Jayasinghe, R. G., Yao, L., Gonzalez-Kozlova, E., Dasari, S., Kim-Schulze, S., Rahman, A., Patton, J., Fiala, M., Cheloni, G., Kourelis, T., Dhodapkar, M. V., Vij, R., Mehr, S., Hamilton, M., Cho, H. J., Auclair, D., Avigan, D. E., & 4 others, Dec 2023, In: npj Genomic Medicine. 8, 1, 3.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy
Van Oekelen, O., Nath, K., Mouhieddine, T. H., Farzana, T., Aleman, A., Melnekoff, D. T., Ghodke-Puranik, Y., Shah, G. L., Lesokhin, A., Giralt, S., Thibaud, S., Rossi, A., Rodriguez, C., Sanchez, L., Richter, J., Richard, S., Cho, H. J., Chari, A., Usmani, S. Z., Jagannath, S., & 3 others, 16 Feb 2023, In: Blood. 141, 7, p. 756-765 10 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Trial designs and endpoints for immune therapies in multiple myeloma
Lancman, G., Moshier, E., Cho, H. J., Parekh, S., Richard, S., Richter, J., Rodriguez, C., Rossi, A., Sanchez, L., Jagannath, S. & Chari, A., Mar 2023, In: American Journal of Hematology. 98, S2, p. S35-S45Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations -
A Three-Gene Signature Predicts Response to Selinexor in Multiple Myeloma
Restrepo, P., Bhalla, S., Ghodke-Puranik, Y., Aleman, A., Leshchenko, V., Melnekoff, D. T., Agte, S., Jiang, J., Madduri, D., Richter, J., Richard, S., Chari, A., Cho, H. J., Jagannath, S., Walker, C. J., Landesman, Y., Laganà, A. & Parekh, S., 1 Jun 2022, In: JCO Precision Oncology. 6, e2200147.Research output: Contribution to journal › Article › peer-review
4 Scopus citations
Press/Media
-
New Findings from Icahn School of Medicine at Mount Sinai Describe Advances in Multiple Myeloma (Trial Designs and Endpoints for Immune Therapies In Multiple Myeloma)
Erin Moshier, Joshua Richter, Guido Lancman, Samir Parekh, Sundar Jagannath, Ajai Chari & Hearn Cho
8/12/22
1 item of Media coverage
Press/Media
-
Icahn School of Medicine at Mount Sinai Details Findings in Myeloma (Bridging Advanced Myeloma Patients To Subsequent Treatments and Clinical Trials With Classical Chemotherapy and Stem Cell Support)
Erin Moshier, Joshua Richter, Tarek Mouhieddine, Amir Steinberg, Samir Parekh, Ajai Chari & Hearn Cho
22/11/22
1 item of Media coverage
Press/Media
-
MMRF Data Fuels Greater Understanding of Multiple Myeloma Drug Resistance, Mutational Landscape
24/08/22
1 item of Media coverage
Press/Media
-
Molecular Drivers of Multiple Myeloma and Treatment Resistance Identified
28/07/22
1 item of Media coverage
Press/Media
-
Researchers find link between genetic mutations and cancer treatment resistance
26/07/22 → 27/07/22
5 items of Media coverage
Press/Media